Sri Navodaya Superspeciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 98.32%
(FY 2023)
- Ebitda 98.32%
(FY 2023)
- Net Worth -106.42%
(FY 2023)
- Total Assets %
(FY 2023)
About Sri Navodaya Superspeciality Hospitals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajender Reddy and Prashanth Tatikonda serve as directors at the Company.
- CIN/LLPIN
U85191TG2012PTC081062
- Company No.
081062
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2012
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Navodaya Superspeciality Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajender Reddy  | Director | 22-May-2012 | Current |
| Prashanth Tatikonda | Director | 22-May-2012 | Current |
Financial Performance of Sri Navodaya Superspeciality Hospitals.
Sri Navodaya Superspeciality Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 98.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 106.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Navodaya Superspeciality Hospitals?
In 2023, Sri Navodaya Superspeciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Resolution Fetal Medicine Centre And Research Institute Private LimitedActive 4 years 11 monthsPrashanth Tatikonda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Navodaya Superspeciality Hospitals?
Unlock and access historical data on people associated with Sri Navodaya Superspeciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Navodaya Superspeciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Navodaya Superspeciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
